93 related articles for article (PubMed ID: 1409781)
1. Cocaine-induced suppression of renin secretion is partially mediated by serotonergic mechanisms.
Levy AD; Rittenhouse PA; Li Q; Kerr JE; Cabrera TM; Battaglia G; Van de Kar LD
Pharmacol Biochem Behav; 1992 Jul; 42(3):481-6. PubMed ID: 1409781
[TBL] [Abstract][Full Text] [Related]
2. Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons.
Levy AD; Li QA; Kerr JE; Rittenhouse PA; Milonas G; Cabrera TM; Battaglia G; Alvarez Sanz MC; Van de Kar LD
J Pharmacol Exp Ther; 1991 Nov; 259(2):495-500. PubMed ID: 1658300
[TBL] [Abstract][Full Text] [Related]
3. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
4. Repeated injections of cocaine inhibit the serotonergic regulation of prolactin and renin secretion in rats.
Levy AD; Rittenhouse PA; Li Q; Bonadonna AM; Alvarez Sanz MC; Kerr JE; Bethea CL; van de Kar LD
Brain Res; 1992 May; 580(1-2):6-11. PubMed ID: 1504817
[TBL] [Abstract][Full Text] [Related]
5. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
6. Cocaine-induced suppression of renin secretion is mediated in the brain: investigation of cardiovascular and local anesthetic mechanisms.
Van de Kar LD; Levy AD; Rittenhouse PA; Li Q; Alvarez Sanz MC; Yracheta J; Kunimoto K
Brain Res Bull; 1992 May; 28(5):837-42. PubMed ID: 1617466
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
8. Central stimulation of renin secretion through serotonergic, noncardiovascular mechanisms.
Rittenhouse PA; Bakkum EA; Levy AD; Li Q; Yracheta JM; Kunimoto K; van de Kar LD
Neuroendocrinology; 1994 Aug; 60(2):205-14. PubMed ID: 7969778
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
Haddjeri N; de Montigny C; Blier P
Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
11. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
12. ICV injection of the serotonin 5-HT1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms.
Van de Kar LD; Alvarez Sanz MC; Yracheta JM; Kunimoto K; Li Q; Levy AD; Rittenhouse PA
Pharmacol Biochem Behav; 1994 Jun; 48(2):429-36. PubMed ID: 8090811
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
Van de Kar LD; Carnes M; Maslowski RJ; Bonadonna AM; Rittenhouse PA; Kunimoto K; Piechowski RA; Bethea CL
J Pharmacol Exp Ther; 1989 Nov; 251(2):428-34. PubMed ID: 2553918
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
15. Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin, but not adrenocorticotropin secretion.
Levy AD; Rittenhouse PA; Bonadonna AM; Alvarez Sanz MC; Bethea CL; Van de Kar LD
Eur J Pharmacol; 1993 Sep; 241(2-3):275-8. PubMed ID: 8243563
[TBL] [Abstract][Full Text] [Related]
16. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats.
Schenk S
Pharmacol Biochem Behav; 2000 Oct; 67(2):363-9. PubMed ID: 11124402
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
18. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion.
Rittenhouse PA; Li Q; Levy AD; Van de Kar LD
Brain Res; 1992 Oct; 593(1):105-13. PubMed ID: 1458311
[TBL] [Abstract][Full Text] [Related]
19. Brain catecholamines mediate the delayed reduction in renin release after injection of fenfluramine.
Van de Kar LD; Richardson Morton KD; Brownfield MS
Brain Res; 1994 Jan; 634(1):77-84. PubMed ID: 8156394
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1991 Feb; 38(2):353-7. PubMed ID: 1676173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
